Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1925 of 3173 entries
View as:

A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01435382 Org: User:
Start: 10/31/11 End: 04/30/12 Due: 04/30/13

Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

Phase: N/A Priority: Normal
NCT ID: NCT04930445 Org: User:
Start: 02/04/22 End: 10/10/24 Due: 10/10/25

Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

Phase: N/A Priority: Normal
NCT ID: NCT00150410 Org: User:
Start: 01/31/03 End: 06/30/07 Due: 06/30/08

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

Phase: N/A Priority: Normal
NCT ID: NCT01383993 Org: User:
Start: 09/30/11 End: 05/31/13 Due: 05/31/14

Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03954158 Org: User:
Start: 06/15/19 End: 12/16/19 Due: 12/16/20

CP-751,871 Treatment For Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01536145 Org: User:
Start: 12/31/03 End: 06/30/08 Due: 06/30/09

A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00747058 Org: User:
Start: 08/31/08 End: 12/31/08 Due: 12/31/09

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00065468 Org: User:
Start: 07/31/03 End: 03/31/11 Due: 03/31/12

A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

Phase: N/A Priority: Normal
NCT ID: NCT00652925 Org: User:
Start: 10/31/02 End: 04/30/05 Due: 04/30/06

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Phase: N/A Priority: Normal
NCT ID: NCT01461993 Org: User:
Start: 09/28/11 End: 07/06/13 Due: 07/06/14

Escape Smoke Project: Non-Intervention Non-Drug Multicenter Study on the Real-life Effectiveness of Smoking Cessation in General Practice in Denmark

Phase: N/A Priority: Normal
NCT ID: NCT01544621 Org: User:
Start: 11/30/11 End: 05/31/13 Due: 05/31/14

Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01260857 Org: User:
Start: 03/31/13 End: 02/28/15 Due: 02/28/16

A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died

Phase: N/A Priority: Normal
NCT ID: NCT00061438 Org: User:
Start: 02/28/03 End: 12/31/04 Due: 12/31/05

Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13

Phase: N/A Priority: Normal
NCT ID: NCT05408429 Org: User:
Start: 06/24/22 End: 06/01/23 Due: 06/01/24

A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)

Phase: N/A Priority: Normal
NCT ID: NCT04721977 Org: User:
Start: 04/08/21 End: 11/25/25 Due: 11/25/26

A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06705569 Org: User:
Start: 12/20/24 End: 04/04/25 Due: 04/04/26

Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns

Phase: N/A Priority: Normal
NCT ID: NCT04351334 Org: User:
Start: 03/01/20 End: 11/01/22 Due: 11/01/23

Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

Phase: N/A Priority: Normal
NCT ID: NCT00174408 Org: User:
Start: 03/31/90 End: 02/28/05 Due: 02/28/06

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Phase: N/A Priority: Normal
NCT ID: NCT01473420 Org: User:
Start: 01/17/12 End: 02/28/14 Due: 02/28/15

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.

Phase: N/A Priority: Normal
NCT ID: NCT00150436 Org: User:
Start: 02/28/02 End: 07/31/05 Due: 07/31/06

A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04165317 Org: User:
Start: 12/30/19 End: 12/02/26 Due: 12/02/27

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00227240 Org: User:
Start: 04/30/05 End: 06/30/09 Due: 06/30/10

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT04152018 Org: User:
Start: 11/13/19 End: 12/10/24 Due: 12/10/25

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT00559910 Org: User:
Start: 02/29/08 End: 12/31/09 Due: 12/31/10

A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01232556 Org: User:
Start: 04/04/11 End: 03/28/14 Due: 03/28/15